• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血红蛋白遗传疾病:日益被忽视的全球健康负担。

The inherited disorders of haemoglobin: an increasingly neglected global health burden.

机构信息

Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom.

出版信息

Indian J Med Res. 2011 Oct;134(4):493-7.

PMID:22089613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3237249/
Abstract

An estimated 300,000 babies are born each year with a severe inherited disease of haemoglobin and that over 80 per cent of these births occur in low- or middle-income countries. As these countries go through the epidemiological transition, characterized by a reduction in childhood and infant mortality due to improved public health measures, infants who had previously died of these conditions before they were recognised are now surviving to present for diagnosis and treatment. For a variety of reasons, even in the rich countries there are limited data about the true frequency, natural history, and survival of patients with these disorders, information that is absolutely critical towards providing governments and international health agencies with accurate information about the true global health burden of these conditions. The situation can only be improved by major action on the part of the rich countries together with the formation of partnerships between rich and poor countries and input from the major international health agencies and funding organisations.

摘要

每年估计有 30 万名婴儿出生时患有严重的血红蛋白遗传性疾病,其中超过 80%的病例发生在低收入和中等收入国家。随着这些国家经历流行病学转变,由于公共卫生措施的改善,儿童和婴儿死亡率降低,以前因这些疾病而在得到诊断和治疗之前死亡的婴儿现在能够存活下来接受诊断和治疗。由于各种原因,即使在富裕国家,关于这些疾病的真实频率、自然史和患者存活率的数据也非常有限,而这些信息对于向政府和国际卫生机构提供有关这些疾病真实全球健康负担的准确信息至关重要。只有富裕国家采取重大行动,富裕国家和贫穷国家建立伙伴关系,并得到主要国际卫生机构和供资组织的投入,这种情况才能得到改善。

相似文献

1
The inherited disorders of haemoglobin: an increasingly neglected global health burden.血红蛋白遗传疾病:日益被忽视的全球健康负担。
Indian J Med Res. 2011 Oct;134(4):493-7.
2
The inherited diseases of hemoglobin are an emerging global health burden.血红蛋白遗传疾病是一个正在浮现的全球性健康负担。
Blood. 2010 Jun 3;115(22):4331-6. doi: 10.1182/blood-2010-01-251348. Epub 2010 Mar 16.
3
The population dynamics of hemoglobins A, A, F and S in the context of the hemoglobinopathies HbS and α-thalassemia in Kenyan infants.肯尼亚婴儿中镰状血红蛋白病(HbS)和α地中海贫血背景下血红蛋白A、A2、F和S的群体动态。
Haematologica. 2019 May;104(5):e184-e186. doi: 10.3324/haematol.2018.199596. Epub 2018 Nov 22.
4
Global epidemiology of haemoglobin disorders and derived service indicators.血红蛋白疾病的全球流行病学及相关服务指标
Bull World Health Organ. 2008 Jun;86(6):480-7. doi: 10.2471/blt.06.036673.
5
The challenge of haemoglobinopathies in resource-poor countries.资源匮乏国家血红蛋白病的挑战。
Br J Haematol. 2011 Sep;154(6):736-44. doi: 10.1111/j.1365-2141.2011.08742.x. Epub 2011 Jul 5.
6
Age dependence of the gene frequency of alpha-thalassemia in sickle cell anemia in Cuba.古巴镰状细胞贫血中α地中海贫血基因频率的年龄依赖性
Blood. 1996 Sep 1;88(5):1898-9.
7
Sickle cell screening in Uganda: High burden, human immunodeficiency virus comorbidity, and genetic modifiers.乌干达镰状细胞筛查:负担沉重、人类免疫缺陷病毒合并感染以及遗传修饰因子。
Pediatr Blood Cancer. 2019 Aug;66(8):e27807. doi: 10.1002/pbc.27807. Epub 2019 May 16.
8
Thalassemia as a global health problem: recent progress toward its control in the developing countries.地中海贫血症作为一个全球性健康问题:发展中国家在控制该病方面的最新进展。
Ann N Y Acad Sci. 2010 Aug;1202:17-23. doi: 10.1111/j.1749-6632.2010.05546.x.
9
[Thalassemia and sickle-cell disease in Norway].[挪威的地中海贫血和镰状细胞病]
Tidsskr Nor Laegeforen. 2001 Feb 28;121(6):678-80.
10
Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease.镰状细胞病患儿队列中第一个十年的临床事件。镰状细胞病合作研究。
Blood. 1995 Jul 15;86(2):776-83.

引用本文的文献

1
Establishment of a Comprehensive Platform for Sustained Delivery of Yoga Therapy for Sickle Cell Anemia in Rural and Remote Tribal Pocket in India.在印度农村和偏远部落地区建立镰状细胞贫血瑜伽疗法持续提供综合平台。
Int J Yoga. 2024 Sep-Dec;17(3):182-194. doi: 10.4103/ijoy.ijoy_133_24. Epub 2024 Dec 14.
2
A cellular reporter system to evaluate endogenous fetal hemoglobin induction and screen for therapeutic compounds.一种用于评估内源性胎儿血红蛋白诱导并筛选治疗性化合物的细胞报告系统。
Hemasphere. 2024 Aug 6;8(8):e139. doi: 10.1002/hem3.139. eCollection 2024 Aug.
3
Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy.利用 HSC 靶向 LNP 构建致死性α-地中海贫血小鼠模型及通过慢病毒基因治疗进行治疗。
Blood. 2024 Oct 10;144(15):1633-1645. doi: 10.1182/blood.2023023349.
4
The Characteristics of Compound Heterozygosity for Hemoglobin G-Makassar with Hb E in Malaysia.马来西亚血红蛋白G-望加锡与血红蛋白E复合杂合性的特征
J Blood Med. 2024 May 29;15:255-264. doi: 10.2147/JBM.S432849. eCollection 2024.
5
Haematological screening and its correlation with sociodemographic profile among the indigenous communities in and around Puducherry.本地治里及其周边地区原住民社区的血液学筛查及其与社会人口学特征的相关性。
J Family Med Prim Care. 2023 Aug;12(8):1629-1635. doi: 10.4103/jfmpc.jfmpc_2275_22. Epub 2023 Aug 29.
6
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.姜黄和姜黄素在慢性病防治中的作用:来自临床试验的经验教训。
ACS Pharmacol Transl Sci. 2023 Mar 6;6(4):447-518. doi: 10.1021/acsptsci.2c00012. eCollection 2023 Apr 14.
7
Red cell distribution width as a surrogate marker of haemoglobinopathies in western Kenya.红细胞分布宽度作为肯尼亚西部血红蛋白病的替代标志物。
Afr J Lab Med. 2022 Apr 29;11(1):1644. doi: 10.4102/ajlm.v11i1.1644. eCollection 2022.
8
Serum or plasma ferritin concentration as an index of iron deficiency and overload.血清或血浆铁蛋白浓度作为铁缺乏和铁过载的指标。
Cochrane Database Syst Rev. 2021 May 24;5(5):CD011817. doi: 10.1002/14651858.CD011817.pub2.
9
A Novel Earwax Method to Measure Acute and Chronic Glucose Levels.一种用于测量急性和慢性葡萄糖水平的新型耳垢检测方法。
Diagnostics (Basel). 2020 Dec 10;10(12):1069. doi: 10.3390/diagnostics10121069.
10
Hemoglobinopathies in Iran: An Updated Review.伊朗的血红蛋白病:最新综述
Int J Hematol Oncol Stem Cell Res. 2020 Apr 1;14(2):140-150.

本文引用的文献

1
Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis.镰状细胞基因的全球分布与疟疾假说的地理验证。
Nat Commun. 2010 Nov 2;1:104. doi: 10.1038/ncomms1104.
2
The inherited diseases of hemoglobin are an emerging global health burden.血红蛋白遗传疾病是一个正在浮现的全球性健康负担。
Blood. 2010 Jun 3;115(22):4331-6. doi: 10.1182/blood-2010-01-251348. Epub 2010 Mar 16.
3
Epidemiology of beta-thalassaemia in Western India: mapping the frequencies and mutations in sub-regions of Maharashtra and Gujarat.印度西部β-地中海贫血的流行病学:马哈拉施特拉邦和古吉拉特邦各地区频率和突变的绘制。
Br J Haematol. 2010 Jun;149(5):739-47. doi: 10.1111/j.1365-2141.2010.08131.x. Epub 2010 Mar 3.
4
Epistatic interactions between genetic disorders of hemoglobin can explain why the sickle-cell gene is uncommon in the Mediterranean.地中海地区镰状细胞基因罕见的原因可以用血红蛋白遗传疾病的上位性相互作用来解释。
Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21242-6. doi: 10.1073/pnas.0910840106. Epub 2009 Dec 1.
5
Global epidemiology of haemoglobin disorders and derived service indicators.血红蛋白疾病的全球流行病学及相关服务指标
Bull World Health Organ. 2008 Jun;86(6):480-7. doi: 10.2471/blt.06.036673.
6
Studies in haemoglobin E beta-thalassaemia.血红蛋白Eβ地中海贫血的研究
Br J Haematol. 2008 May;141(3):388-97. doi: 10.1111/j.1365-2141.2008.07126.x.
7
Genetic variation and susceptibility to infection: the red cell and malaria.遗传变异与感染易感性:红细胞与疟疾
Br J Haematol. 2008 May;141(3):276-86. doi: 10.1111/j.1365-2141.2008.07085.x.
8
Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait.α+地中海贫血的疟疾保护作用与镰状细胞性状之间的负上位性。
Nat Genet. 2005 Nov;37(11):1253-7. doi: 10.1038/ng1660. Epub 2005 Oct 16.
9
How malaria has affected the human genome and what human genetics can teach us about malaria.疟疾如何影响人类基因组,以及人类遗传学能让我们对疟疾有哪些了解。
Am J Hum Genet. 2005 Aug;77(2):171-92. doi: 10.1086/432519. Epub 2005 Jul 6.
10
Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.接受输血和去铁胺治疗的重型地中海贫血患者的生存情况及并发症
Haematologica. 2004 Oct;89(10):1187-93.